238 related articles for article (PubMed ID: 25145705)
21. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
Li T; Li Y
Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor BLU promotes TRAIL-induced apoptosis by downregulating NF-κB signaling in nasopharyngeal carcinoma.
Zhou J; Huang Z; Wang Z; Liu S; Grandien A; Ernberg I; He Z; Zhang X
Oncotarget; 2017 Jul; 8(27):43853-43865. PubMed ID: 28029652
[TBL] [Abstract][Full Text] [Related]
23. NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition.
Zhang W; Guo Q; Liu G; Zheng F; Chen J; Huang D; Ding L; Yang X; Song E; Xiang Y; Yao H
PLoS Genet; 2019 Aug; 15(8):e1008325. PubMed ID: 31430288
[TBL] [Abstract][Full Text] [Related]
24. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
Li N; Feng L; Han HQ; Yuan J; Qi XK; Lian YF; Kuang BH; Zhang YC; Deng CC; Zhang HJ; Yao YY; Xu M; He GP; Zhao BC; Gao L; Feng QS; Chen LZ; Yang L; Yang D; Zeng YX
Cancer Lett; 2016 Oct; 381(1):14-22. PubMed ID: 27424523
[TBL] [Abstract][Full Text] [Related]
25. NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.
Chen CC; Liu HP; Chao M; Liang Y; Tsang NM; Huang HY; Wu CC; Chang YS
Oncogene; 2014 Jul; 33(28):3648-59. PubMed ID: 23975427
[TBL] [Abstract][Full Text] [Related]
26. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
[No Abstract] [Full Text] [Related]
27. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.
He S; Niu G; Shang J; Deng Y; Wan Z; Zhang C; You Z; Shen H
J Exp Clin Cancer Res; 2017 Oct; 36(1):137. PubMed ID: 28978336
[TBL] [Abstract][Full Text] [Related]
28. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
[TBL] [Abstract][Full Text] [Related]
29. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
Zhao Y; Wang P; Wu Q
Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
[TBL] [Abstract][Full Text] [Related]
31. IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.
Phoon YP; Cheung AK; Cheung FM; Chan KF; Wong S; Wong BW; Tung SY; Yau CC; Ng WT; Lung ML
Int J Cancer; 2016 Jan; 138(1):160-70. PubMed ID: 26227166
[TBL] [Abstract][Full Text] [Related]
32. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
33. MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.
Li LN; Xiao T; Yi HM; Zheng Z; Qu JQ; Huang W; Ye X; Yi H; Lu SS; Li XH; Xiao ZQ
Mol Cancer Ther; 2017 Oct; 16(10):2094-2106. PubMed ID: 28698199
[TBL] [Abstract][Full Text] [Related]
34. Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through a NF-κB-independent and ERK-dependent pathway.
Xie Y; Li Y; Peng X; Henderson F; Deng L; Chen N
Oral Oncol; 2013 Dec; 49(12):1113-20. PubMed ID: 24075781
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of TBL1XR1 in predicting liver metastasis for early stage colorectal cancer.
Liu H; Xu Y; Zhang Q; Yang H; Shi W; Liu Z; Li K; Gong Z; Ning S; Li S; Chen Y
Surg Oncol; 2017 Mar; 26(1):13-20. PubMed ID: 28317580
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.
Hwang CF; Shiu LY; Su LJ; Yu-Fang Yin ; Wang WS; Huang SC; Chiu TJ; Huang CC; Zhen YY; Tsai HT; Fang FM; Huang TL; Chen CH
PLoS One; 2013; 8(12):e84218. PubMed ID: 24386352
[TBL] [Abstract][Full Text] [Related]
37. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.
Peng H; Zhang J; Zhang PP; Chen L; Tang LL; Yang XJ; He QM; Wen X; Sun Y; Liu N; Li YQ; Ma J
J Exp Clin Cancer Res; 2019 Jan; 38(1):11. PubMed ID: 30621723
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J
Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612
[TBL] [Abstract][Full Text] [Related]
39. Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling.
Lu J; Bang H; Kim SM; Cho SJ; Ashktorab H; Smoot DT; Zheng CH; Ryeom SW; Yoon SS; Yoon C; Lee JH
Oncogene; 2021 Feb; 40(5):922-936. PubMed ID: 33288885
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.
Valentine R; Dawson CW; Hu C; Shah KM; Owen TJ; Date KL; Maia SP; Shao J; Arrand JR; Young LS; O'Neil JD
Mol Cancer; 2010 Jan; 9():1. PubMed ID: 20051109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
